Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981447 · ClinicalTrials.gov registry record · Phase 3
IV Lacosamide: The Safety of Intravenous Lacosamide
A Phase 3 study of Epilepsy, sponsored by Le Bonheur Children's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01981447: Completed Phase 3 study of Epilepsy, sponsored by Le Bonheur Children's Hospital.
NCT01981447 is a Phase 3 study of Epilepsy that has completed, run by Le Bonheur Children's Hospital. The registered enrollment target is 40 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01981447, a Phase 3 study of Epilepsy, has completed, sponsored by Le Bonheur Children's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety of IV Lacosamide in children ages 4-35.
Primary Outcome
Bradycardia, hypotension, fatigue, nausea, somnolence.
Conditions Studied
Interventions
- DRUG IV Lacosamide
Study Locations (1)
Tennessee
- Lebonheur Children's Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
What the finished NCT01981447 record still lists
NCT01981447 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which IV Lacosamide is the first listed.
NCT01981447 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01981447 about?
NCT01981447 is a clinical study titled "IV Lacosamide: The Safety of Intravenous Lacosamide". The purpose of this study is to evaluate the safety of IV Lacosamide in children ages 4-35.
What is the current status of trial NCT01981447?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2010-04. Estimated completion is 2012-08.
What conditions does trial NCT01981447 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT01981447?
The interventions under investigation include: IV Lacosamide (DRUG).
Who is sponsoring clinical trial NCT01981447?
This trial is sponsored by Le Bonheur Children's Hospital, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01981447 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01981447's enrollment target sits among peer trials
40 92nd of 160 higher than 61 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
RECRUITING · Phase 3
-
Lemborexant Treatment of Insomnia Linked to Epilepsy
RECRUITING · Phase 3
-
RNS System NAUTILUS Study
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
COMPLETED · Phase 3
-
Clobazam in Patients With Lennox-Gastaut Syndrome
COMPLETED · Phase 3
-
Pediatric Epilepsy Study
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia